Clinical Trial Update: Prevention of New Onset AF After TAVI (PAF-TAVI Trial) [Phase 3]

View source ↗

Summary

Phase 3 trial update for prevention of new onset atrial fibrillation after transcatheter aortic valve implantation (TAVI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Luis Nombela Franco | Conditions: Atrial Fibrillation New Onset | Phase 3 | Status: UNKNOWN